HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$1.30
Day range
$1.24 - $1.32
Year range
$1.23 - $3.45
Market cap
7.75M USD
Avg Volume
32.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.22M | -13.48% |
Operating expense | 11.16M | -2.56% |
Net income | 788.00K | 458.18% |
Net profit margin | 4.86 | 515.38% |
Earnings per share | — | — |
EBITDA | 961.00K | -80.53% |
Effective tax rate | -74.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.40M | 4.45% |
Total assets | 116.23M | -11.45% |
Total liabilities | 85.46M | -13.14% |
Total equity | 30.76M | — |
Shares outstanding | 6.17M | — |
Price to book | 0.26 | — |
Return on assets | -0.81% | — |
Return on capital | -1.97% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 788.00K | 458.18% |
Cash from operations | 2.90M | 2,251.85% |
Cash from investing | 145.00K | 183.33% |
Cash from financing | -2.76M | -2,090.48% |
Net change in cash | 290.00K | 166.67% |
Free cash flow | 1.93M | 933.36% |
About
Founded
2002
Headquarters
Website
Employees
99
